Skip to main content

Table 2 JRQLQ scores at baseline and second year of treatment (n = 9)

From: Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study

  Baseline 2nd year p value
Nasal and eye symptoms 1.67 (1.5–2.0) 0.67 (0–1.17) * 0.0141
QOL related questionnaires
 Usual daily activities 1.0 (0.8–1.4) 0 (0–0.8) 0.0575
 Outdoor activities 1.0 (0.5–2.0) 0 (0–0.5) * 0.0350
 Social functioning 0.67 (0.33–1.0) 0 (0–0) 0.584
 Impaired sleeping 2.0 (1.0–2.0) 0 (0–1.0) 0.0655
 Physical problems 1.0 (1.0–2.0) 0 (0–1.0) 0.114
 Emotional functions 1.0 (0.5–1.5) 0 (0–0) 0.106
General state 4.0 (3.8–4.0) 2.0 (1.0–2.0) * 0.0498
  1. The data are presented as median with interquartile ranges
  2. Comparison of each JRQLQ score between baseline and second year were calculated using the Wilcoxon signed rank test. *p < 0.05